Lifecore Biomedical, Inc. Shareholders' Equity for the year ending May 26, 2024: USD 53.90 M

Lifecore Biomedical, Inc. Shareholders' Equity is USD 53.90 M for the year ending May 26, 2024, a -3,026.28% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Lifecore Biomedical, Inc. Shareholders' Equity for the year ending May 28, 2023 was USD -1.84 M, a -101.70% change year over year.
  • Lifecore Biomedical, Inc. Shareholders' Equity for the year ending May 29, 2022 was USD 108.14 M, a -46.67% change year over year.
  • Lifecore Biomedical, Inc. Shareholders' Equity for the year ending May 31, 2021 was USD 202.78 M, a -12.23% change year over year.
  • Lifecore Biomedical, Inc. Shareholders' Equity for the year ending May 31, 2020 was USD 231.04 M, a -14.47% change year over year.
Key Data
Date Shareholders' Equity Cash and Short-Term Investments Receivables Inventory